Seer Inc (SEER) - Total Assets
Based on the latest financial reports, Seer Inc (SEER) holds total assets worth $256.64 Million USD as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Seer Inc - Total Assets Trend (2018–2025)
This chart illustrates how Seer Inc's total assets have evolved over time, based on quarterly financial data. Also see market cap of Seer Inc for the company's overall valuation and market capitalisation.
Seer Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
Seer Inc's total assets of $256.64 Million consist of 68.1% current assets and 31.9% non-current assets. Review debt load of Seer Inc to assess the company's total debt and financial obligations.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 16.0% |
| Accounts Receivable | $5.95 Million | 2.0% |
| Inventory | $7.79 Million | 2.6% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2018–2025)
This chart illustrates how Seer Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Seer Inc (SEER) stock price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Seer Inc's current assets represent 68.1% of total assets in 2025, a decrease from 92.6% in 2018.
- Cash Position: Cash and equivalents constituted 16.0% of total assets in 2025, down from 91.9% in 2018.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2018.
- Asset Diversification: The largest asset category is inventory at 2.6% of total assets.
Seer Inc Competitors by Total Assets
Key competitors of Seer Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
ALK-Abelló A/S
CO:ALK-B
|
Denmark | Dkr9.17 Billion |
|
Mirum Pharmaceuticals Inc
NASDAQ:MIRM
|
USA | $890.92 Million |
|
Xiamen Amoytop Biotech Co Ltd
SHG:688278
|
China | CN¥3.21 Billion |
|
BB Biotech AG
SW:BION
|
Switzerland | CHF3.09 Billion |
|
Soleno Therapeutics Inc
NASDAQ:SLNO
|
USA | $608.39 Million |
|
Nanobiotix
NASDAQ:NBTX
|
USA | $67.76 Million |
|
Inhibrx Biosciences, Inc.
NASDAQ:INBX
|
USA | $183.97 Million |
|
Wuhan Keqian Biology Co Ltd
SHG:688526
|
China | CN¥4.75 Billion |
Seer Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 14.74 | 19.15 | 53.83 |
| Quick Ratio | 14.06 | 18.51 | 53.57 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $154.83 Million | $213.85 Million | $504.71 Million |
Seer Inc - Advanced Valuation Insights
This section examines the relationship between Seer Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.48 |
| Latest Market Cap to Assets Ratio | 0.36 |
| Asset Growth Rate (YoY) | -19.2% |
| Total Assets | $296.08 Million |
| Market Capitalization | $106.31 Million USD |
Valuation Analysis
Below Book Valuation: The market values Seer Inc's assets below their book value (0.36x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Seer Inc's assets decreased by 19.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Seer Inc (2018–2025)
The table below shows the annual total assets of Seer Inc from 2018 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $296.08 Million | -19.23% |
| 2024-12-31 | $366.60 Million | -15.97% |
| 2023-12-31 | $436.27 Million | -10.59% |
| 2022-12-31 | $487.93 Million | -9.50% |
| 2021-12-31 | $539.14 Million | +21.89% |
| 2020-12-31 | $442.32 Million | +374.41% |
| 2019-12-31 | $93.24 Million | +176.70% |
| 2018-12-31 | $33.70 Million | -- |
About Seer Inc
Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa. The company offers Proteograph Product Suite, an integrated solution, which includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis … Read more